News
On average, developing a new drug takes 12 years and costs $2.6 billion, with 9 out of 10 drugs entering clinical trials failing to enter the market 1. While digital technology...
Approximately 20 to 25 participants representing pharma, biotech, academia, and government will come together in July to help define the future of AI in pharmaceutical R&D...
Michael K. O'Brien, Ph.D., President and Founder of NGT BioPharma Consultants, has been named as an Industry Influence on The Medicine Maker 2019 Power List. The list, which...
12
Page 2 of 2
